GÖTEBORG, Sweden--(BUSINESS WIRE)--Meda (STO:MEDAA) has signed an agreement to divest the manufacturing unit in Lakewood, New Jersey, to the contract manufacturer DPT. The manufacturing facility is dedicated to global supply of the product MUSE. As part of the agreement Meda has entered into a long term supply agreement with DPT with improved cost of goods for MUSE.
The divestment is in line with Meda´s ambitions to optimize manufacturing. The financial impact of the transaction is not material.
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 120 countries worldwide and the company is represented by its own organizations in close to 60 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.
This information was brought to you by Cision http://news.cision.com